Global GnRHa Peptide Drugs Supply, Demand and Key Producers, 2023-2029
The global GnRHa Peptide Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Relin drugs refer to a large class of synthetic polypeptide drugs based on the structure of gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone-releasing hormone (LHRH). Clinically, it is mainly used to treat symptoms such as low sexual function, anovulation, and delayed puberty, such as prostate cancer, uterine fibroids, breast cancer, endometriosis, and precocious puberty. At present, the main relin drugs in clinical use include: three main products of leuprorelin, goserelin and triptorelin.
This report studies the global GnRHa Peptide Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GnRHa Peptide Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GnRHa Peptide Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GnRHa Peptide Drugs total production and demand, 2018-2029, (K Units)
Global GnRHa Peptide Drugs total production value, 2018-2029, (USD Million)
Global GnRHa Peptide Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GnRHa Peptide Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: GnRHa Peptide Drugs domestic production, consumption, key domestic manufacturers and share
Global GnRHa Peptide Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global GnRHa Peptide Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GnRHa Peptide Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global GnRHa Peptide Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON and Ipsen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GnRHa Peptide Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GnRHa Peptide Drugs Market, By Region:
1. How big is the global GnRHa Peptide Drugs market?
2. What is the demand of the global GnRHa Peptide Drugs market?
3. What is the year over year growth of the global GnRHa Peptide Drugs market?
4. What is the production and production value of the global GnRHa Peptide Drugs market?
5. Who are the key producers in the global GnRHa Peptide Drugs market?
6. What are the growth factors driving the market demand?
Relin drugs refer to a large class of synthetic polypeptide drugs based on the structure of gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone-releasing hormone (LHRH). Clinically, it is mainly used to treat symptoms such as low sexual function, anovulation, and delayed puberty, such as prostate cancer, uterine fibroids, breast cancer, endometriosis, and precocious puberty. At present, the main relin drugs in clinical use include: three main products of leuprorelin, goserelin and triptorelin.
This report studies the global GnRHa Peptide Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GnRHa Peptide Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GnRHa Peptide Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GnRHa Peptide Drugs total production and demand, 2018-2029, (K Units)
Global GnRHa Peptide Drugs total production value, 2018-2029, (USD Million)
Global GnRHa Peptide Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GnRHa Peptide Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: GnRHa Peptide Drugs domestic production, consumption, key domestic manufacturers and share
Global GnRHa Peptide Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global GnRHa Peptide Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global GnRHa Peptide Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global GnRHa Peptide Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, AbbVie, AstraZeneca, Ferring, TerSera Therapeutics, Astellas Pharma, Takeda, LIVZON and Ipsen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GnRHa Peptide Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global GnRHa Peptide Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prostap
- Zoladex
- Triptorelin
- Histrelin
- Nafarelin
- Others
- Endometriosis
- Uterine Fibroids
- Artificial Assisted Reproduction
- Prostate Cancer
- Central Precocious Puberty
- Others
- Pfizer
- AbbVie
- AstraZeneca
- Ferring
- TerSera Therapeutics
- Astellas Pharma
- Takeda
- LIVZON
- Ipsen
- Sanofi
- Endo
- Tocris Bioscience
- Sigma-Aldrich
- MedChem Express
- Arbor Pharmaceuticals
1. How big is the global GnRHa Peptide Drugs market?
2. What is the demand of the global GnRHa Peptide Drugs market?
3. What is the year over year growth of the global GnRHa Peptide Drugs market?
4. What is the production and production value of the global GnRHa Peptide Drugs market?
5. Who are the key producers in the global GnRHa Peptide Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 GnRHa Peptide Drugs Introduction
1.2 World GnRHa Peptide Drugs Supply & Forecast
1.2.1 World GnRHa Peptide Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World GnRHa Peptide Drugs Production (2018-2029)
1.2.3 World GnRHa Peptide Drugs Pricing Trends (2018-2029)
1.3 World GnRHa Peptide Drugs Production by Region (Based on Production Site)
1.3.1 World GnRHa Peptide Drugs Production Value by Region (2018-2029)
1.3.2 World GnRHa Peptide Drugs Production by Region (2018-2029)
1.3.3 World GnRHa Peptide Drugs Average Price by Region (2018-2029)
1.3.4 North America GnRHa Peptide Drugs Production (2018-2029)
1.3.5 Europe GnRHa Peptide Drugs Production (2018-2029)
1.3.6 China GnRHa Peptide Drugs Production (2018-2029)
1.3.7 Japan GnRHa Peptide Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GnRHa Peptide Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GnRHa Peptide Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World GnRHa Peptide Drugs Demand (2018-2029)
2.2 World GnRHa Peptide Drugs Consumption by Region
2.2.1 World GnRHa Peptide Drugs Consumption by Region (2018-2023)
2.2.2 World GnRHa Peptide Drugs Consumption Forecast by Region (2024-2029)
2.3 United States GnRHa Peptide Drugs Consumption (2018-2029)
2.4 China GnRHa Peptide Drugs Consumption (2018-2029)
2.5 Europe GnRHa Peptide Drugs Consumption (2018-2029)
2.6 Japan GnRHa Peptide Drugs Consumption (2018-2029)
2.7 South Korea GnRHa Peptide Drugs Consumption (2018-2029)
2.8 ASEAN GnRHa Peptide Drugs Consumption (2018-2029)
2.9 India GnRHa Peptide Drugs Consumption (2018-2029)
3 WORLD GNRHA PEPTIDE DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GnRHa Peptide Drugs Production Value by Manufacturer (2018-2023)
3.2 World GnRHa Peptide Drugs Production by Manufacturer (2018-2023)
3.3 World GnRHa Peptide Drugs Average Price by Manufacturer (2018-2023)
3.4 GnRHa Peptide Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GnRHa Peptide Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GnRHa Peptide Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for GnRHa Peptide Drugs in 2022
3.6 GnRHa Peptide Drugs Market: Overall Company Footprint Analysis
3.6.1 GnRHa Peptide Drugs Market: Region Footprint
3.6.2 GnRHa Peptide Drugs Market: Company Product Type Footprint
3.6.3 GnRHa Peptide Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GnRHa Peptide Drugs Production Value Comparison
4.1.1 United States VS China: GnRHa Peptide Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: GnRHa Peptide Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GnRHa Peptide Drugs Production Comparison
4.2.1 United States VS China: GnRHa Peptide Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GnRHa Peptide Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GnRHa Peptide Drugs Consumption Comparison
4.3.1 United States VS China: GnRHa Peptide Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: GnRHa Peptide Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GnRHa Peptide Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GnRHa Peptide Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers GnRHa Peptide Drugs Production (2018-2023)
4.5 China Based GnRHa Peptide Drugs Manufacturers and Market Share
4.5.1 China Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GnRHa Peptide Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers GnRHa Peptide Drugs Production (2018-2023)
4.6 Rest of World Based GnRHa Peptide Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GnRHa Peptide Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers GnRHa Peptide Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GnRHa Peptide Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prostap
5.2.2 Zoladex
5.2.3 Triptorelin
5.2.4 Histrelin
5.2.5 Nafarelin
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World GnRHa Peptide Drugs Production by Type (2018-2029)
5.3.2 World GnRHa Peptide Drugs Production Value by Type (2018-2029)
5.3.3 World GnRHa Peptide Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GnRHa Peptide Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Endometriosis
6.2.2 Uterine Fibroids
6.2.3 Artificial Assisted Reproduction
6.2.4 Prostate Cancer
6.2.5 Central Precocious Puberty
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World GnRHa Peptide Drugs Production by Application (2018-2029)
6.3.2 World GnRHa Peptide Drugs Production Value by Application (2018-2029)
6.3.3 World GnRHa Peptide Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer GnRHa Peptide Drugs Product and Services
7.1.4 Pfizer GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AbbVie
7.2.1 AbbVie Details
7.2.2 AbbVie Major Business
7.2.3 AbbVie GnRHa Peptide Drugs Product and Services
7.2.4 AbbVie GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AbbVie Recent Developments/Updates
7.2.6 AbbVie Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca GnRHa Peptide Drugs Product and Services
7.3.4 AstraZeneca GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 Ferring
7.4.1 Ferring Details
7.4.2 Ferring Major Business
7.4.3 Ferring GnRHa Peptide Drugs Product and Services
7.4.4 Ferring GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Ferring Recent Developments/Updates
7.4.6 Ferring Competitive Strengths & Weaknesses
7.5 TerSera Therapeutics
7.5.1 TerSera Therapeutics Details
7.5.2 TerSera Therapeutics Major Business
7.5.3 TerSera Therapeutics GnRHa Peptide Drugs Product and Services
7.5.4 TerSera Therapeutics GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 TerSera Therapeutics Recent Developments/Updates
7.5.6 TerSera Therapeutics Competitive Strengths & Weaknesses
7.6 Astellas Pharma
7.6.1 Astellas Pharma Details
7.6.2 Astellas Pharma Major Business
7.6.3 Astellas Pharma GnRHa Peptide Drugs Product and Services
7.6.4 Astellas Pharma GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Astellas Pharma Recent Developments/Updates
7.6.6 Astellas Pharma Competitive Strengths & Weaknesses
7.7 Takeda
7.7.1 Takeda Details
7.7.2 Takeda Major Business
7.7.3 Takeda GnRHa Peptide Drugs Product and Services
7.7.4 Takeda GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Takeda Recent Developments/Updates
7.7.6 Takeda Competitive Strengths & Weaknesses
7.8 LIVZON
7.8.1 LIVZON Details
7.8.2 LIVZON Major Business
7.8.3 LIVZON GnRHa Peptide Drugs Product and Services
7.8.4 LIVZON GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 LIVZON Recent Developments/Updates
7.8.6 LIVZON Competitive Strengths & Weaknesses
7.9 Ipsen
7.9.1 Ipsen Details
7.9.2 Ipsen Major Business
7.9.3 Ipsen GnRHa Peptide Drugs Product and Services
7.9.4 Ipsen GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Ipsen Recent Developments/Updates
7.9.6 Ipsen Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi GnRHa Peptide Drugs Product and Services
7.10.4 Sanofi GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Endo
7.11.1 Endo Details
7.11.2 Endo Major Business
7.11.3 Endo GnRHa Peptide Drugs Product and Services
7.11.4 Endo GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Endo Recent Developments/Updates
7.11.6 Endo Competitive Strengths & Weaknesses
7.12 Tocris Bioscience
7.12.1 Tocris Bioscience Details
7.12.2 Tocris Bioscience Major Business
7.12.3 Tocris Bioscience GnRHa Peptide Drugs Product and Services
7.12.4 Tocris Bioscience GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Tocris Bioscience Recent Developments/Updates
7.12.6 Tocris Bioscience Competitive Strengths & Weaknesses
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Details
7.13.2 Sigma-Aldrich Major Business
7.13.3 Sigma-Aldrich GnRHa Peptide Drugs Product and Services
7.13.4 Sigma-Aldrich GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Sigma-Aldrich Recent Developments/Updates
7.13.6 Sigma-Aldrich Competitive Strengths & Weaknesses
7.14 MedChem Express
7.14.1 MedChem Express Details
7.14.2 MedChem Express Major Business
7.14.3 MedChem Express GnRHa Peptide Drugs Product and Services
7.14.4 MedChem Express GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 MedChem Express Recent Developments/Updates
7.14.6 MedChem Express Competitive Strengths & Weaknesses
7.15 Arbor Pharmaceuticals
7.15.1 Arbor Pharmaceuticals Details
7.15.2 Arbor Pharmaceuticals Major Business
7.15.3 Arbor Pharmaceuticals GnRHa Peptide Drugs Product and Services
7.15.4 Arbor Pharmaceuticals GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Arbor Pharmaceuticals Recent Developments/Updates
7.15.6 Arbor Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GnRHa Peptide Drugs Industry Chain
8.2 GnRHa Peptide Drugs Upstream Analysis
8.2.1 GnRHa Peptide Drugs Core Raw Materials
8.2.2 Main Manufacturers of GnRHa Peptide Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GnRHa Peptide Drugs Production Mode
8.6 GnRHa Peptide Drugs Procurement Model
8.7 GnRHa Peptide Drugs Industry Sales Model and Sales Channels
8.7.1 GnRHa Peptide Drugs Sales Model
8.7.2 GnRHa Peptide Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 GnRHa Peptide Drugs Introduction
1.2 World GnRHa Peptide Drugs Supply & Forecast
1.2.1 World GnRHa Peptide Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World GnRHa Peptide Drugs Production (2018-2029)
1.2.3 World GnRHa Peptide Drugs Pricing Trends (2018-2029)
1.3 World GnRHa Peptide Drugs Production by Region (Based on Production Site)
1.3.1 World GnRHa Peptide Drugs Production Value by Region (2018-2029)
1.3.2 World GnRHa Peptide Drugs Production by Region (2018-2029)
1.3.3 World GnRHa Peptide Drugs Average Price by Region (2018-2029)
1.3.4 North America GnRHa Peptide Drugs Production (2018-2029)
1.3.5 Europe GnRHa Peptide Drugs Production (2018-2029)
1.3.6 China GnRHa Peptide Drugs Production (2018-2029)
1.3.7 Japan GnRHa Peptide Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 GnRHa Peptide Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GnRHa Peptide Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World GnRHa Peptide Drugs Demand (2018-2029)
2.2 World GnRHa Peptide Drugs Consumption by Region
2.2.1 World GnRHa Peptide Drugs Consumption by Region (2018-2023)
2.2.2 World GnRHa Peptide Drugs Consumption Forecast by Region (2024-2029)
2.3 United States GnRHa Peptide Drugs Consumption (2018-2029)
2.4 China GnRHa Peptide Drugs Consumption (2018-2029)
2.5 Europe GnRHa Peptide Drugs Consumption (2018-2029)
2.6 Japan GnRHa Peptide Drugs Consumption (2018-2029)
2.7 South Korea GnRHa Peptide Drugs Consumption (2018-2029)
2.8 ASEAN GnRHa Peptide Drugs Consumption (2018-2029)
2.9 India GnRHa Peptide Drugs Consumption (2018-2029)
3 WORLD GNRHA PEPTIDE DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GnRHa Peptide Drugs Production Value by Manufacturer (2018-2023)
3.2 World GnRHa Peptide Drugs Production by Manufacturer (2018-2023)
3.3 World GnRHa Peptide Drugs Average Price by Manufacturer (2018-2023)
3.4 GnRHa Peptide Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GnRHa Peptide Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GnRHa Peptide Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for GnRHa Peptide Drugs in 2022
3.6 GnRHa Peptide Drugs Market: Overall Company Footprint Analysis
3.6.1 GnRHa Peptide Drugs Market: Region Footprint
3.6.2 GnRHa Peptide Drugs Market: Company Product Type Footprint
3.6.3 GnRHa Peptide Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GnRHa Peptide Drugs Production Value Comparison
4.1.1 United States VS China: GnRHa Peptide Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: GnRHa Peptide Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GnRHa Peptide Drugs Production Comparison
4.2.1 United States VS China: GnRHa Peptide Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: GnRHa Peptide Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GnRHa Peptide Drugs Consumption Comparison
4.3.1 United States VS China: GnRHa Peptide Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: GnRHa Peptide Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GnRHa Peptide Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GnRHa Peptide Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers GnRHa Peptide Drugs Production (2018-2023)
4.5 China Based GnRHa Peptide Drugs Manufacturers and Market Share
4.5.1 China Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GnRHa Peptide Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers GnRHa Peptide Drugs Production (2018-2023)
4.6 Rest of World Based GnRHa Peptide Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GnRHa Peptide Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers GnRHa Peptide Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World GnRHa Peptide Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prostap
5.2.2 Zoladex
5.2.3 Triptorelin
5.2.4 Histrelin
5.2.5 Nafarelin
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World GnRHa Peptide Drugs Production by Type (2018-2029)
5.3.2 World GnRHa Peptide Drugs Production Value by Type (2018-2029)
5.3.3 World GnRHa Peptide Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World GnRHa Peptide Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Endometriosis
6.2.2 Uterine Fibroids
6.2.3 Artificial Assisted Reproduction
6.2.4 Prostate Cancer
6.2.5 Central Precocious Puberty
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World GnRHa Peptide Drugs Production by Application (2018-2029)
6.3.2 World GnRHa Peptide Drugs Production Value by Application (2018-2029)
6.3.3 World GnRHa Peptide Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer GnRHa Peptide Drugs Product and Services
7.1.4 Pfizer GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 AbbVie
7.2.1 AbbVie Details
7.2.2 AbbVie Major Business
7.2.3 AbbVie GnRHa Peptide Drugs Product and Services
7.2.4 AbbVie GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AbbVie Recent Developments/Updates
7.2.6 AbbVie Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca GnRHa Peptide Drugs Product and Services
7.3.4 AstraZeneca GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 Ferring
7.4.1 Ferring Details
7.4.2 Ferring Major Business
7.4.3 Ferring GnRHa Peptide Drugs Product and Services
7.4.4 Ferring GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Ferring Recent Developments/Updates
7.4.6 Ferring Competitive Strengths & Weaknesses
7.5 TerSera Therapeutics
7.5.1 TerSera Therapeutics Details
7.5.2 TerSera Therapeutics Major Business
7.5.3 TerSera Therapeutics GnRHa Peptide Drugs Product and Services
7.5.4 TerSera Therapeutics GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 TerSera Therapeutics Recent Developments/Updates
7.5.6 TerSera Therapeutics Competitive Strengths & Weaknesses
7.6 Astellas Pharma
7.6.1 Astellas Pharma Details
7.6.2 Astellas Pharma Major Business
7.6.3 Astellas Pharma GnRHa Peptide Drugs Product and Services
7.6.4 Astellas Pharma GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Astellas Pharma Recent Developments/Updates
7.6.6 Astellas Pharma Competitive Strengths & Weaknesses
7.7 Takeda
7.7.1 Takeda Details
7.7.2 Takeda Major Business
7.7.3 Takeda GnRHa Peptide Drugs Product and Services
7.7.4 Takeda GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Takeda Recent Developments/Updates
7.7.6 Takeda Competitive Strengths & Weaknesses
7.8 LIVZON
7.8.1 LIVZON Details
7.8.2 LIVZON Major Business
7.8.3 LIVZON GnRHa Peptide Drugs Product and Services
7.8.4 LIVZON GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 LIVZON Recent Developments/Updates
7.8.6 LIVZON Competitive Strengths & Weaknesses
7.9 Ipsen
7.9.1 Ipsen Details
7.9.2 Ipsen Major Business
7.9.3 Ipsen GnRHa Peptide Drugs Product and Services
7.9.4 Ipsen GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Ipsen Recent Developments/Updates
7.9.6 Ipsen Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi GnRHa Peptide Drugs Product and Services
7.10.4 Sanofi GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Endo
7.11.1 Endo Details
7.11.2 Endo Major Business
7.11.3 Endo GnRHa Peptide Drugs Product and Services
7.11.4 Endo GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Endo Recent Developments/Updates
7.11.6 Endo Competitive Strengths & Weaknesses
7.12 Tocris Bioscience
7.12.1 Tocris Bioscience Details
7.12.2 Tocris Bioscience Major Business
7.12.3 Tocris Bioscience GnRHa Peptide Drugs Product and Services
7.12.4 Tocris Bioscience GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Tocris Bioscience Recent Developments/Updates
7.12.6 Tocris Bioscience Competitive Strengths & Weaknesses
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Details
7.13.2 Sigma-Aldrich Major Business
7.13.3 Sigma-Aldrich GnRHa Peptide Drugs Product and Services
7.13.4 Sigma-Aldrich GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Sigma-Aldrich Recent Developments/Updates
7.13.6 Sigma-Aldrich Competitive Strengths & Weaknesses
7.14 MedChem Express
7.14.1 MedChem Express Details
7.14.2 MedChem Express Major Business
7.14.3 MedChem Express GnRHa Peptide Drugs Product and Services
7.14.4 MedChem Express GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 MedChem Express Recent Developments/Updates
7.14.6 MedChem Express Competitive Strengths & Weaknesses
7.15 Arbor Pharmaceuticals
7.15.1 Arbor Pharmaceuticals Details
7.15.2 Arbor Pharmaceuticals Major Business
7.15.3 Arbor Pharmaceuticals GnRHa Peptide Drugs Product and Services
7.15.4 Arbor Pharmaceuticals GnRHa Peptide Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Arbor Pharmaceuticals Recent Developments/Updates
7.15.6 Arbor Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 GnRHa Peptide Drugs Industry Chain
8.2 GnRHa Peptide Drugs Upstream Analysis
8.2.1 GnRHa Peptide Drugs Core Raw Materials
8.2.2 Main Manufacturers of GnRHa Peptide Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GnRHa Peptide Drugs Production Mode
8.6 GnRHa Peptide Drugs Procurement Model
8.7 GnRHa Peptide Drugs Industry Sales Model and Sales Channels
8.7.1 GnRHa Peptide Drugs Sales Model
8.7.2 GnRHa Peptide Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World GnRHa Peptide Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GnRHa Peptide Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World GnRHa Peptide Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World GnRHa Peptide Drugs Production Value Market Share by Region (2018-2023)
Table 5. World GnRHa Peptide Drugs Production Value Market Share by Region (2024-2029)
Table 6. World GnRHa Peptide Drugs Production by Region (2018-2023) & (K Units)
Table 7. World GnRHa Peptide Drugs Production by Region (2024-2029) & (K Units)
Table 8. World GnRHa Peptide Drugs Production Market Share by Region (2018-2023)
Table 9. World GnRHa Peptide Drugs Production Market Share by Region (2024-2029)
Table 10. World GnRHa Peptide Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World GnRHa Peptide Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. GnRHa Peptide Drugs Major Market Trends
Table 13. World GnRHa Peptide Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World GnRHa Peptide Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World GnRHa Peptide Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World GnRHa Peptide Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GnRHa Peptide Drugs Producers in 2022
Table 18. World GnRHa Peptide Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key GnRHa Peptide Drugs Producers in 2022
Table 20. World GnRHa Peptide Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global GnRHa Peptide Drugs Company Evaluation Quadrant
Table 22. World GnRHa Peptide Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GnRHa Peptide Drugs Production Site of Key Manufacturer
Table 24. GnRHa Peptide Drugs Market: Company Product Type Footprint
Table 25. GnRHa Peptide Drugs Market: Company Product Application Footprint
Table 26. GnRHa Peptide Drugs Competitive Factors
Table 27. GnRHa Peptide Drugs New Entrant and Capacity Expansion Plans
Table 28. GnRHa Peptide Drugs Mergers & Acquisitions Activity
Table 29. United States VS China GnRHa Peptide Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GnRHa Peptide Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China GnRHa Peptide Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GnRHa Peptide Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GnRHa Peptide Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GnRHa Peptide Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers GnRHa Peptide Drugs Production Market Share (2018-2023)
Table 37. China Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GnRHa Peptide Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GnRHa Peptide Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GnRHa Peptide Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers GnRHa Peptide Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GnRHa Peptide Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GnRHa Peptide Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GnRHa Peptide Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers GnRHa Peptide Drugs Production Market Share (2018-2023)
Table 47. World GnRHa Peptide Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GnRHa Peptide Drugs Production by Type (2018-2023) & (K Units)
Table 49. World GnRHa Peptide Drugs Production by Type (2024-2029) & (K Units)
Table 50. World GnRHa Peptide Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World GnRHa Peptide Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World GnRHa Peptide Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World GnRHa Peptide Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World GnRHa Peptide Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GnRHa Peptide Drugs Production by Application (2018-2023) & (K Units)
Table 56. World GnRHa Peptide Drugs Production by Application (2024-2029) & (K Units)
Table 57. World GnRHa Peptide Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World GnRHa Peptide Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World GnRHa Peptide Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World GnRHa Peptide Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer GnRHa Peptide Drugs Product and Services
Table 64. Pfizer GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AbbVie Basic Information, Manufacturing Base and Competitors
Table 68. AbbVie Major Business
Table 69. AbbVie GnRHa Peptide Drugs Product and Services
Table 70. AbbVie GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AbbVie Recent Developments/Updates
Table 72. AbbVie Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca GnRHa Peptide Drugs Product and Services
Table 76. AstraZeneca GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. Ferring Basic Information, Manufacturing Base and Competitors
Table 80. Ferring Major Business
Table 81. Ferring GnRHa Peptide Drugs Product and Services
Table 82. Ferring GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Ferring Recent Developments/Updates
Table 84. Ferring Competitive Strengths & Weaknesses
Table 85. TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. TerSera Therapeutics Major Business
Table 87. TerSera Therapeutics GnRHa Peptide Drugs Product and Services
Table 88. TerSera Therapeutics GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. TerSera Therapeutics Recent Developments/Updates
Table 90. TerSera Therapeutics Competitive Strengths & Weaknesses
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Major Business
Table 93. Astellas Pharma GnRHa Peptide Drugs Product and Services
Table 94. Astellas Pharma GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Astellas Pharma Recent Developments/Updates
Table 96. Astellas Pharma Competitive Strengths & Weaknesses
Table 97. Takeda Basic Information, Manufacturing Base and Competitors
Table 98. Takeda Major Business
Table 99. Takeda GnRHa Peptide Drugs Product and Services
Table 100. Takeda GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Takeda Recent Developments/Updates
Table 102. Takeda Competitive Strengths & Weaknesses
Table 103. LIVZON Basic Information, Manufacturing Base and Competitors
Table 104. LIVZON Major Business
Table 105. LIVZON GnRHa Peptide Drugs Product and Services
Table 106. LIVZON GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. LIVZON Recent Developments/Updates
Table 108. LIVZON Competitive Strengths & Weaknesses
Table 109. Ipsen Basic Information, Manufacturing Base and Competitors
Table 110. Ipsen Major Business
Table 111. Ipsen GnRHa Peptide Drugs Product and Services
Table 112. Ipsen GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Ipsen Recent Developments/Updates
Table 114. Ipsen Competitive Strengths & Weaknesses
Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. Sanofi Major Business
Table 117. Sanofi GnRHa Peptide Drugs Product and Services
Table 118. Sanofi GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sanofi Recent Developments/Updates
Table 120. Sanofi Competitive Strengths & Weaknesses
Table 121. Endo Basic Information, Manufacturing Base and Competitors
Table 122. Endo Major Business
Table 123. Endo GnRHa Peptide Drugs Product and Services
Table 124. Endo GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Endo Recent Developments/Updates
Table 126. Endo Competitive Strengths & Weaknesses
Table 127. Tocris Bioscience Basic Information, Manufacturing Base and Competitors
Table 128. Tocris Bioscience Major Business
Table 129. Tocris Bioscience GnRHa Peptide Drugs Product and Services
Table 130. Tocris Bioscience GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Tocris Bioscience Recent Developments/Updates
Table 132. Tocris Bioscience Competitive Strengths & Weaknesses
Table 133. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 134. Sigma-Aldrich Major Business
Table 135. Sigma-Aldrich GnRHa Peptide Drugs Product and Services
Table 136. Sigma-Aldrich GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Sigma-Aldrich Recent Developments/Updates
Table 138. Sigma-Aldrich Competitive Strengths & Weaknesses
Table 139. MedChem Express Basic Information, Manufacturing Base and Competitors
Table 140. MedChem Express Major Business
Table 141. MedChem Express GnRHa Peptide Drugs Product and Services
Table 142. MedChem Express GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. MedChem Express Recent Developments/Updates
Table 144. Arbor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 145. Arbor Pharmaceuticals Major Business
Table 146. Arbor Pharmaceuticals GnRHa Peptide Drugs Product and Services
Table 147. Arbor Pharmaceuticals GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of GnRHa Peptide Drugs Upstream (Raw Materials)
Table 149. GnRHa Peptide Drugs Typical Customers
Table 150. GnRHa Peptide Drugs Typical Distributors
Table 1. World GnRHa Peptide Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GnRHa Peptide Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World GnRHa Peptide Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World GnRHa Peptide Drugs Production Value Market Share by Region (2018-2023)
Table 5. World GnRHa Peptide Drugs Production Value Market Share by Region (2024-2029)
Table 6. World GnRHa Peptide Drugs Production by Region (2018-2023) & (K Units)
Table 7. World GnRHa Peptide Drugs Production by Region (2024-2029) & (K Units)
Table 8. World GnRHa Peptide Drugs Production Market Share by Region (2018-2023)
Table 9. World GnRHa Peptide Drugs Production Market Share by Region (2024-2029)
Table 10. World GnRHa Peptide Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World GnRHa Peptide Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. GnRHa Peptide Drugs Major Market Trends
Table 13. World GnRHa Peptide Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World GnRHa Peptide Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World GnRHa Peptide Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World GnRHa Peptide Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GnRHa Peptide Drugs Producers in 2022
Table 18. World GnRHa Peptide Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key GnRHa Peptide Drugs Producers in 2022
Table 20. World GnRHa Peptide Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global GnRHa Peptide Drugs Company Evaluation Quadrant
Table 22. World GnRHa Peptide Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GnRHa Peptide Drugs Production Site of Key Manufacturer
Table 24. GnRHa Peptide Drugs Market: Company Product Type Footprint
Table 25. GnRHa Peptide Drugs Market: Company Product Application Footprint
Table 26. GnRHa Peptide Drugs Competitive Factors
Table 27. GnRHa Peptide Drugs New Entrant and Capacity Expansion Plans
Table 28. GnRHa Peptide Drugs Mergers & Acquisitions Activity
Table 29. United States VS China GnRHa Peptide Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GnRHa Peptide Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China GnRHa Peptide Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GnRHa Peptide Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GnRHa Peptide Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GnRHa Peptide Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers GnRHa Peptide Drugs Production Market Share (2018-2023)
Table 37. China Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GnRHa Peptide Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GnRHa Peptide Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GnRHa Peptide Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers GnRHa Peptide Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based GnRHa Peptide Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GnRHa Peptide Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GnRHa Peptide Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GnRHa Peptide Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers GnRHa Peptide Drugs Production Market Share (2018-2023)
Table 47. World GnRHa Peptide Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GnRHa Peptide Drugs Production by Type (2018-2023) & (K Units)
Table 49. World GnRHa Peptide Drugs Production by Type (2024-2029) & (K Units)
Table 50. World GnRHa Peptide Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World GnRHa Peptide Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World GnRHa Peptide Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World GnRHa Peptide Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World GnRHa Peptide Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GnRHa Peptide Drugs Production by Application (2018-2023) & (K Units)
Table 56. World GnRHa Peptide Drugs Production by Application (2024-2029) & (K Units)
Table 57. World GnRHa Peptide Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World GnRHa Peptide Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World GnRHa Peptide Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World GnRHa Peptide Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer GnRHa Peptide Drugs Product and Services
Table 64. Pfizer GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. AbbVie Basic Information, Manufacturing Base and Competitors
Table 68. AbbVie Major Business
Table 69. AbbVie GnRHa Peptide Drugs Product and Services
Table 70. AbbVie GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AbbVie Recent Developments/Updates
Table 72. AbbVie Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca GnRHa Peptide Drugs Product and Services
Table 76. AstraZeneca GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. Ferring Basic Information, Manufacturing Base and Competitors
Table 80. Ferring Major Business
Table 81. Ferring GnRHa Peptide Drugs Product and Services
Table 82. Ferring GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Ferring Recent Developments/Updates
Table 84. Ferring Competitive Strengths & Weaknesses
Table 85. TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. TerSera Therapeutics Major Business
Table 87. TerSera Therapeutics GnRHa Peptide Drugs Product and Services
Table 88. TerSera Therapeutics GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. TerSera Therapeutics Recent Developments/Updates
Table 90. TerSera Therapeutics Competitive Strengths & Weaknesses
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Major Business
Table 93. Astellas Pharma GnRHa Peptide Drugs Product and Services
Table 94. Astellas Pharma GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Astellas Pharma Recent Developments/Updates
Table 96. Astellas Pharma Competitive Strengths & Weaknesses
Table 97. Takeda Basic Information, Manufacturing Base and Competitors
Table 98. Takeda Major Business
Table 99. Takeda GnRHa Peptide Drugs Product and Services
Table 100. Takeda GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Takeda Recent Developments/Updates
Table 102. Takeda Competitive Strengths & Weaknesses
Table 103. LIVZON Basic Information, Manufacturing Base and Competitors
Table 104. LIVZON Major Business
Table 105. LIVZON GnRHa Peptide Drugs Product and Services
Table 106. LIVZON GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. LIVZON Recent Developments/Updates
Table 108. LIVZON Competitive Strengths & Weaknesses
Table 109. Ipsen Basic Information, Manufacturing Base and Competitors
Table 110. Ipsen Major Business
Table 111. Ipsen GnRHa Peptide Drugs Product and Services
Table 112. Ipsen GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Ipsen Recent Developments/Updates
Table 114. Ipsen Competitive Strengths & Weaknesses
Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. Sanofi Major Business
Table 117. Sanofi GnRHa Peptide Drugs Product and Services
Table 118. Sanofi GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sanofi Recent Developments/Updates
Table 120. Sanofi Competitive Strengths & Weaknesses
Table 121. Endo Basic Information, Manufacturing Base and Competitors
Table 122. Endo Major Business
Table 123. Endo GnRHa Peptide Drugs Product and Services
Table 124. Endo GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Endo Recent Developments/Updates
Table 126. Endo Competitive Strengths & Weaknesses
Table 127. Tocris Bioscience Basic Information, Manufacturing Base and Competitors
Table 128. Tocris Bioscience Major Business
Table 129. Tocris Bioscience GnRHa Peptide Drugs Product and Services
Table 130. Tocris Bioscience GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Tocris Bioscience Recent Developments/Updates
Table 132. Tocris Bioscience Competitive Strengths & Weaknesses
Table 133. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 134. Sigma-Aldrich Major Business
Table 135. Sigma-Aldrich GnRHa Peptide Drugs Product and Services
Table 136. Sigma-Aldrich GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Sigma-Aldrich Recent Developments/Updates
Table 138. Sigma-Aldrich Competitive Strengths & Weaknesses
Table 139. MedChem Express Basic Information, Manufacturing Base and Competitors
Table 140. MedChem Express Major Business
Table 141. MedChem Express GnRHa Peptide Drugs Product and Services
Table 142. MedChem Express GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. MedChem Express Recent Developments/Updates
Table 144. Arbor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 145. Arbor Pharmaceuticals Major Business
Table 146. Arbor Pharmaceuticals GnRHa Peptide Drugs Product and Services
Table 147. Arbor Pharmaceuticals GnRHa Peptide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of GnRHa Peptide Drugs Upstream (Raw Materials)
Table 149. GnRHa Peptide Drugs Typical Customers
Table 150. GnRHa Peptide Drugs Typical Distributors
LIST OF FIGURES
Figure 1. GnRHa Peptide Drugs Picture
Figure 2. World GnRHa Peptide Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GnRHa Peptide Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 5. World GnRHa Peptide Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World GnRHa Peptide Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World GnRHa Peptide Drugs Production Market Share by Region (2018-2029)
Figure 8. North America GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 9. Europe GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 10. China GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 11. Japan GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 12. GnRHa Peptide Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 15. World GnRHa Peptide Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 17. China GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 22. India GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of GnRHa Peptide Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GnRHa Peptide Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GnRHa Peptide Drugs Markets in 2022
Figure 26. United States VS China: GnRHa Peptide Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GnRHa Peptide Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GnRHa Peptide Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GnRHa Peptide Drugs Production Market Share 2022
Figure 30. China Based Manufacturers GnRHa Peptide Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GnRHa Peptide Drugs Production Market Share 2022
Figure 32. World GnRHa Peptide Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GnRHa Peptide Drugs Production Value Market Share by Type in 2022
Figure 34. Prostap
Figure 35. Zoladex
Figure 36. Triptorelin
Figure 37. Histrelin
Figure 38. Nafarelin
Figure 39. Others
Figure 40. World GnRHa Peptide Drugs Production Market Share by Type (2018-2029)
Figure 41. World GnRHa Peptide Drugs Production Value Market Share by Type (2018-2029)
Figure 42. World GnRHa Peptide Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World GnRHa Peptide Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World GnRHa Peptide Drugs Production Value Market Share by Application in 2022
Figure 45. Endometriosis
Figure 46. Uterine Fibroids
Figure 47. Artificial Assisted Reproduction
Figure 48. Prostate Cancer
Figure 49. Central Precocious Puberty
Figure 50. Others
Figure 51. World GnRHa Peptide Drugs Production Market Share by Application (2018-2029)
Figure 52. World GnRHa Peptide Drugs Production Value Market Share by Application (2018-2029)
Figure 53. World GnRHa Peptide Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 54. GnRHa Peptide Drugs Industry Chain
Figure 55. GnRHa Peptide Drugs Procurement Model
Figure 56. GnRHa Peptide Drugs Sales Model
Figure 57. GnRHa Peptide Drugs Sales Channels, Direct Sales, and Distribution
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. GnRHa Peptide Drugs Picture
Figure 2. World GnRHa Peptide Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GnRHa Peptide Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 5. World GnRHa Peptide Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World GnRHa Peptide Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World GnRHa Peptide Drugs Production Market Share by Region (2018-2029)
Figure 8. North America GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 9. Europe GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 10. China GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 11. Japan GnRHa Peptide Drugs Production (2018-2029) & (K Units)
Figure 12. GnRHa Peptide Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 15. World GnRHa Peptide Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 17. China GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 22. India GnRHa Peptide Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of GnRHa Peptide Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GnRHa Peptide Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GnRHa Peptide Drugs Markets in 2022
Figure 26. United States VS China: GnRHa Peptide Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GnRHa Peptide Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GnRHa Peptide Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GnRHa Peptide Drugs Production Market Share 2022
Figure 30. China Based Manufacturers GnRHa Peptide Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GnRHa Peptide Drugs Production Market Share 2022
Figure 32. World GnRHa Peptide Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GnRHa Peptide Drugs Production Value Market Share by Type in 2022
Figure 34. Prostap
Figure 35. Zoladex
Figure 36. Triptorelin
Figure 37. Histrelin
Figure 38. Nafarelin
Figure 39. Others
Figure 40. World GnRHa Peptide Drugs Production Market Share by Type (2018-2029)
Figure 41. World GnRHa Peptide Drugs Production Value Market Share by Type (2018-2029)
Figure 42. World GnRHa Peptide Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World GnRHa Peptide Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World GnRHa Peptide Drugs Production Value Market Share by Application in 2022
Figure 45. Endometriosis
Figure 46. Uterine Fibroids
Figure 47. Artificial Assisted Reproduction
Figure 48. Prostate Cancer
Figure 49. Central Precocious Puberty
Figure 50. Others
Figure 51. World GnRHa Peptide Drugs Production Market Share by Application (2018-2029)
Figure 52. World GnRHa Peptide Drugs Production Value Market Share by Application (2018-2029)
Figure 53. World GnRHa Peptide Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 54. GnRHa Peptide Drugs Industry Chain
Figure 55. GnRHa Peptide Drugs Procurement Model
Figure 56. GnRHa Peptide Drugs Sales Model
Figure 57. GnRHa Peptide Drugs Sales Channels, Direct Sales, and Distribution
Figure 58. Methodology
Figure 59. Research Process and Data Source
